

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.27456165 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.27456165 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.95924616 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.95924616 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.37933913 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.91810469 |
| 7 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.87948701 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.62150415 |
| 9 | glutamate secretion (GO:0014047) | 5.61483789 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.60584636 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.60584636 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.60584636 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 5.60344190 |
| 14 | synaptic vesicle maturation (GO:0016188) | 5.60075815 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.54760942 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.47663361 |
| 17 | sodium ion export (GO:0071436) | 5.41029390 |
| 18 | kynurenine metabolic process (GO:0070189) | 5.39330386 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 5.29530614 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.15518643 |
| 21 | cysteine metabolic process (GO:0006534) | 5.15034471 |
| 22 | glyoxylate metabolic process (GO:0046487) | 5.11703626 |
| 23 | regulation of synaptic vesicle transport (GO:1902803) | 5.11098268 |
| 24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.03627072 |
| 25 | postsynaptic membrane organization (GO:0001941) | 5.03357884 |
| 26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.98506521 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 4.91074839 |
| 28 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.85426998 |
| 29 | urea cycle (GO:0000050) | 4.85084414 |
| 30 | urea metabolic process (GO:0019627) | 4.85084414 |
| 31 | negative regulation of inclusion body assembly (GO:0090084) | 4.83457195 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.81889883 |
| 33 | sulfur amino acid catabolic process (GO:0000098) | 4.74805808 |
| 34 | negative regulation of fibrinolysis (GO:0051918) | 4.71088969 |
| 35 | vocalization behavior (GO:0071625) | 4.70985015 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.67646777 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.63509133 |
| 38 | locomotory exploration behavior (GO:0035641) | 4.62977649 |
| 39 | coenzyme catabolic process (GO:0009109) | 4.61306028 |
| 40 | bile acid metabolic process (GO:0008206) | 4.59435547 |
| 41 | protein carboxylation (GO:0018214) | 4.58880814 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.58880814 |
| 43 | indolalkylamine metabolic process (GO:0006586) | 4.58709538 |
| 44 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.56727754 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 4.55898129 |
| 46 | alkaloid metabolic process (GO:0009820) | 4.52645104 |
| 47 | complement activation, alternative pathway (GO:0006957) | 4.50502155 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 4.49003551 |
| 49 | imidazole-containing compound metabolic process (GO:0052803) | 4.48200497 |
| 50 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 4.45215343 |
| 51 | positive regulation of dendritic spine development (GO:0060999) | 4.44478191 |
| 52 | regulation of protein activation cascade (GO:2000257) | 4.44292304 |
| 53 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.43816364 |
| 54 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.43143030 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 4.43086353 |
| 56 | neuron cell-cell adhesion (GO:0007158) | 4.39432509 |
| 57 | cellular ketone body metabolic process (GO:0046950) | 4.33545507 |
| 58 | alpha-amino acid catabolic process (GO:1901606) | 4.30695274 |
| 59 | reverse cholesterol transport (GO:0043691) | 4.30571811 |
| 60 | glutamate metabolic process (GO:0006536) | 4.30135763 |
| 61 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.22041398 |
| 62 | protein-lipid complex remodeling (GO:0034368) | 4.19443453 |
| 63 | macromolecular complex remodeling (GO:0034367) | 4.19443453 |
| 64 | plasma lipoprotein particle remodeling (GO:0034369) | 4.19443453 |
| 65 | regulation of synapse structural plasticity (GO:0051823) | 4.18980029 |
| 66 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.18651130 |
| 67 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17616930 |
| 68 | regulation of triglyceride catabolic process (GO:0010896) | 4.16906422 |
| 69 | triglyceride homeostasis (GO:0070328) | 4.15534574 |
| 70 | acylglycerol homeostasis (GO:0055090) | 4.15534574 |
| 71 | neuronal action potential propagation (GO:0019227) | 4.13546076 |
| 72 | neurotransmitter secretion (GO:0007269) | 4.12333301 |
| 73 | regulation of complement activation (GO:0030449) | 4.11949728 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 4.11870009 |
| 75 | amine catabolic process (GO:0009310) | 4.11247902 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.11247902 |
| 77 | protein localization to synapse (GO:0035418) | 4.10946923 |
| 78 | phospholipid efflux (GO:0033700) | 4.07079854 |
| 79 | lysine metabolic process (GO:0006553) | 4.04222469 |
| 80 | lysine catabolic process (GO:0006554) | 4.04222469 |
| 81 | cellular amino acid catabolic process (GO:0009063) | 4.04159295 |
| 82 | negative regulation of sterol transport (GO:0032372) | 4.01218579 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 4.01218579 |
| 84 | bile acid and bile salt transport (GO:0015721) | 4.00057493 |
| 85 | regulation of inclusion body assembly (GO:0090083) | 3.99818559 |
| 86 | ethanol oxidation (GO:0006069) | 3.99252143 |
| 87 | cerebellar granule cell differentiation (GO:0021707) | 3.95495543 |
| 88 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.93794919 |
| 89 | homocysteine metabolic process (GO:0050667) | 3.90468483 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.90340144 |
| 91 | positive regulation of synapse maturation (GO:0090129) | 3.89680753 |
| 92 | presynaptic membrane assembly (GO:0097105) | 3.85241835 |
| 93 | aldehyde catabolic process (GO:0046185) | 3.83967253 |
| 94 | cellular modified amino acid catabolic process (GO:0042219) | 3.83714558 |
| 95 | L-amino acid import (GO:0043092) | 3.82135861 |
| 96 | positive regulation of potassium ion transport (GO:0043268) | 3.80146116 |
| 97 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77456710 |
| 98 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.77124592 |
| 99 | arginine metabolic process (GO:0006525) | 3.76804625 |
| 100 | exploration behavior (GO:0035640) | 3.76617199 |
| 101 | short-chain fatty acid metabolic process (GO:0046459) | 3.75512636 |
| 102 | positive regulation of membrane potential (GO:0045838) | 3.75399876 |
| 103 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.74749635 |
| 104 | ketone body metabolic process (GO:1902224) | 3.74015021 |
| 105 | cellular glucuronidation (GO:0052695) | 3.71719851 |
| 106 | presynaptic membrane organization (GO:0097090) | 3.69701893 |
| 107 | cholesterol efflux (GO:0033344) | 3.68396209 |
| 108 | potassium ion import (GO:0010107) | 3.66598609 |
| 109 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.66212932 |
| 110 | low-density lipoprotein particle remodeling (GO:0034374) | 3.65033429 |
| 111 | plasma lipoprotein particle clearance (GO:0034381) | 3.62564070 |
| 112 | acidic amino acid transport (GO:0015800) | 3.59566969 |
| 113 | cofactor catabolic process (GO:0051187) | 3.59411689 |
| 114 | opsonization (GO:0008228) | 3.58936015 |
| 115 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.58462102 |
| 116 | synaptic vesicle endocytosis (GO:0048488) | 3.58074082 |
| 117 | synaptic transmission, glutamatergic (GO:0035249) | 3.57519528 |
| 118 | organic acid catabolic process (GO:0016054) | 3.57298201 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 3.57298201 |
| 120 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.57068964 |
| 121 | regulation of neurotransmitter secretion (GO:0046928) | 3.56931673 |
| 122 | potassium ion homeostasis (GO:0055075) | 3.55873206 |
| 123 | dendritic spine morphogenesis (GO:0060997) | 3.55434755 |
| 124 | glucuronate metabolic process (GO:0019585) | 3.55248818 |
| 125 | uronic acid metabolic process (GO:0006063) | 3.55248818 |
| 126 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.51397449 |
| 127 | cellular sodium ion homeostasis (GO:0006883) | 3.50505560 |
| 128 | serine family amino acid metabolic process (GO:0009069) | 3.50347120 |
| 129 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.50207311 |
| 130 | neurotransmitter transport (GO:0006836) | 3.49160912 |
| 131 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.47052316 |
| 132 | neurotransmitter uptake (GO:0001504) | 3.47029590 |
| 133 | drug catabolic process (GO:0042737) | 3.45792334 |
| 134 | L-glutamate transport (GO:0015813) | 3.45087974 |
| 135 | neuromuscular process controlling balance (GO:0050885) | 3.42800323 |
| 136 | neuromuscular synaptic transmission (GO:0007274) | 3.42189044 |
| 137 | glycine metabolic process (GO:0006544) | 3.41628909 |
| 138 | blood coagulation, intrinsic pathway (GO:0007597) | 3.40791267 |
| 139 | long-term memory (GO:0007616) | 3.40576113 |
| 140 | negative regulation of lipase activity (GO:0060192) | 3.40287476 |
| 141 | monocarboxylic acid catabolic process (GO:0072329) | 3.35993624 |
| 142 | calcium ion-dependent exocytosis (GO:0017156) | 3.35094033 |
| 143 | gamma-aminobutyric acid transport (GO:0015812) | 3.34834002 |
| 144 | fibrinolysis (GO:0042730) | 3.34430849 |
| 145 | glutamate receptor signaling pathway (GO:0007215) | 3.34368507 |
| 146 | plasma lipoprotein particle assembly (GO:0034377) | 3.34216620 |
| 147 | amino acid import (GO:0043090) | 3.33349977 |
| 148 | NAD biosynthetic process (GO:0009435) | 3.33150240 |
| 149 | drug transmembrane transport (GO:0006855) | 3.32978275 |
| 150 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.32161189 |
| 151 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.30520429 |
| 152 | positive regulation of neurotransmitter transport (GO:0051590) | 3.28696754 |
| 153 | acetyl-CoA metabolic process (GO:0006084) | 3.28194161 |
| 154 | very long-chain fatty acid metabolic process (GO:0000038) | 3.26882899 |
| 155 | indole-containing compound metabolic process (GO:0042430) | 3.25377251 |
| 156 | regulation of vesicle fusion (GO:0031338) | 3.25120661 |
| 157 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.24225935 |
| 158 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.24225935 |
| 159 | auditory behavior (GO:0031223) | 3.24167889 |
| 160 | layer formation in cerebral cortex (GO:0021819) | 3.24062890 |
| 161 | regulation of neurotransmitter transport (GO:0051588) | 3.23504451 |
| 162 | transmission of nerve impulse (GO:0019226) | 3.23030125 |
| 163 | potassium ion export (GO:0071435) | 3.21603801 |
| 164 | regulation of neurotransmitter levels (GO:0001505) | 3.21409440 |
| 165 | response to nitrosative stress (GO:0051409) | 3.21332961 |
| 166 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.21258717 |
| 167 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.21258717 |
| 168 | regulation of postsynaptic membrane potential (GO:0060078) | 3.21066832 |
| 169 | regulation of dendritic spine development (GO:0060998) | 3.20334909 |
| 170 | complement activation, classical pathway (GO:0006958) | 3.20025200 |
| 171 | regulation of plasminogen activation (GO:0010755) | 3.18835268 |
| 172 | regulation of synaptic plasticity (GO:0048167) | 3.18691129 |
| 173 | flavonoid metabolic process (GO:0009812) | 3.18385936 |
| 174 | response to auditory stimulus (GO:0010996) | 3.18007880 |
| 175 | protein activation cascade (GO:0072376) | 3.17880330 |
| 176 | central nervous system myelination (GO:0022010) | 3.17755765 |
| 177 | axon ensheathment in central nervous system (GO:0032291) | 3.17755765 |
| 178 | cytolysis (GO:0019835) | 3.16858156 |
| 179 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.16696765 |
| 180 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.16339722 |
| 181 | dendritic spine organization (GO:0097061) | 3.14859410 |
| 182 | membrane repolarization (GO:0086009) | 3.14247324 |
| 183 | regulation of bile acid biosynthetic process (GO:0070857) | 3.14195942 |
| 184 | cell communication by electrical coupling (GO:0010644) | 3.12016576 |
| 185 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.08544172 |
| 186 | acrosome reaction (GO:0007340) | 3.07972396 |
| 187 | spermatid nucleus differentiation (GO:0007289) | 3.05319466 |
| 188 | regulation of ARF protein signal transduction (GO:0032012) | 3.04880661 |
| 189 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.04347051 |
| 190 | neuron-neuron synaptic transmission (GO:0007270) | 3.02566429 |
| 191 | neuronal ion channel clustering (GO:0045161) | 3.02354565 |
| 192 | cerebral cortex neuron differentiation (GO:0021895) | 2.97078775 |
| 193 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.96554123 |
| 194 | regulation of membrane repolarization (GO:0060306) | 2.95364583 |
| 195 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.94918124 |
| 196 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.94113516 |
| 197 | membrane depolarization during action potential (GO:0086010) | 2.93074962 |
| 198 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.92548711 |
| 199 | mating behavior (GO:0007617) | 2.90843095 |
| 200 | membrane depolarization (GO:0051899) | 2.89125643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.32373270 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47961332 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.53374370 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.35226891 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.99963600 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.18822430 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.70513236 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.23532541 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.12752499 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.91565098 |
| 11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.91339325 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.55393592 |
| 13 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.46108576 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.37088275 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.22936896 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10334517 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.06293676 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.86063143 |
| 19 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.82450088 |
| 20 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.71060061 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.70235481 |
| 22 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64111528 |
| 23 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.60219419 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59024189 |
| 25 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.52958360 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.49122174 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46908354 |
| 28 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.45125013 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44186334 |
| 30 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.43979419 |
| 31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40510263 |
| 32 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.40047833 |
| 33 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.38813954 |
| 34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31418166 |
| 35 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30756541 |
| 36 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30264348 |
| 37 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.29873573 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28952867 |
| 39 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.26661513 |
| 40 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.25404223 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23477230 |
| 42 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.19617526 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19328515 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.18201139 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.16451942 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.15828890 |
| 47 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.15433957 |
| 48 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15290900 |
| 49 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14068037 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.13962015 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.10774709 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09860572 |
| 53 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09766417 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09563426 |
| 55 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09272115 |
| 56 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08028207 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06114437 |
| 58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05313257 |
| 59 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.04893126 |
| 60 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.02839730 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01283074 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00553383 |
| 63 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.00216117 |
| 64 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00074208 |
| 65 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.99528352 |
| 66 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99059547 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98451440 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98284171 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98164932 |
| 70 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.97815612 |
| 71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97762008 |
| 72 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.96817964 |
| 73 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96577911 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96209980 |
| 75 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.96141566 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96114846 |
| 77 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.96001398 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95596328 |
| 79 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94827622 |
| 80 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94215902 |
| 81 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.93478028 |
| 82 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.93089146 |
| 83 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93041039 |
| 84 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.92814307 |
| 85 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92809263 |
| 86 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92438209 |
| 87 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91881493 |
| 88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91662540 |
| 89 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91308344 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90818206 |
| 91 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89937939 |
| 92 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89642664 |
| 93 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89456961 |
| 94 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.89447621 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88032181 |
| 96 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87714785 |
| 97 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.87608291 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87078306 |
| 99 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.86985040 |
| 100 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86282151 |
| 101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85035380 |
| 102 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.84010519 |
| 103 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.83920078 |
| 104 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.83920078 |
| 105 | AR_19668381_ChIP-Seq_PC3_Human | 0.83754016 |
| 106 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.82626447 |
| 107 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.82612008 |
| 108 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.82497757 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81914413 |
| 110 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.81880839 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81821016 |
| 112 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.81552031 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81305405 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81305405 |
| 115 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.81181723 |
| 116 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81038147 |
| 117 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.80802603 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79774055 |
| 119 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79428631 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.79428631 |
| 121 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.78810619 |
| 122 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78688514 |
| 123 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.78299086 |
| 124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77605678 |
| 125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77192393 |
| 126 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76719348 |
| 127 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.74889608 |
| 128 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.74407502 |
| 129 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.74015919 |
| 130 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.73615007 |
| 131 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73210586 |
| 132 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.72437816 |
| 133 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.71935652 |
| 134 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71503610 |
| 135 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71047719 |
| 136 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.70930301 |
| 137 | AR_25329375_ChIP-Seq_VCAP_Human | 0.70851771 |
| 138 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.69731745 |
| 139 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.69590923 |
| 140 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.69418340 |
| 141 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68621538 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.67088567 |
| 143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.66795113 |
| 144 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.66621672 |
| 145 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.66590773 |
| 146 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.66442922 |
| 147 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.65936208 |
| 148 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.65936208 |
| 149 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65706343 |
| 150 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.65137939 |
| 151 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.63932830 |
| 152 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.62893168 |
| 153 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.62439313 |
| 154 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.61287438 |
| 155 | AR_20517297_ChIP-Seq_VCAP_Human | 0.61277245 |
| 156 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.61173395 |
| 157 | NCOR_22424771_ChIP-Seq_293T_Human | 0.60935069 |
| 158 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.59853614 |
| 159 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.59761222 |
| 160 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.59484293 |
| 161 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.59121289 |
| 162 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.58702572 |
| 163 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.58113898 |
| 164 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.57666674 |
| 165 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.57289454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.98204589 |
| 2 | MP0005360_urolithiasis | 6.71706452 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.74362149 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 5.73512283 |
| 5 | MP0005365_abnormal_bile_salt | 5.53689692 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.60497070 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 3.74913054 |
| 8 | MP0003878_abnormal_ear_physiology | 3.74913054 |
| 9 | MP0004270_analgesia | 3.34361895 |
| 10 | MP0003252_abnormal_bile_duct | 3.29173351 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.13134464 |
| 12 | MP0010329_abnormal_lipoprotein_level | 3.08811964 |
| 13 | MP0005083_abnormal_biliary_tract | 3.07920837 |
| 14 | * MP0001486_abnormal_startle_reflex | 2.98193788 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.85062752 |
| 16 | MP0005332_abnormal_amino_acid | 2.65852480 |
| 17 | MP0003195_calcinosis | 2.58591613 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.55064258 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.46685238 |
| 20 | MP0008569_lethality_at_weaning | 2.43852308 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.42593523 |
| 22 | MP0009840_abnormal_foam_cell | 2.28937720 |
| 23 | MP0001970_abnormal_pain_threshold | 2.24973317 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.21663569 |
| 25 | MP0005410_abnormal_fertilization | 2.21431302 |
| 26 | MP0005167_abnormal_blood-brain_barrier | 2.19547064 |
| 27 | MP0003868_abnormal_feces_composition | 2.16834605 |
| 28 | MP0001485_abnormal_pinna_reflex | 2.06553007 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.91443688 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.87379536 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.85532807 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.76654206 |
| 33 | MP0000609_abnormal_liver_physiology | 1.76512529 |
| 34 | MP0010386_abnormal_urinary_bladder | 1.72430620 |
| 35 | MP0004885_abnormal_endolymph | 1.68009059 |
| 36 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61157133 |
| 37 | MP0002822_catalepsy | 1.57604400 |
| 38 | MP0003631_nervous_system_phenotype | 1.54662177 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.53113445 |
| 40 | MP0000778_abnormal_nervous_system | 1.52291606 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.51448688 |
| 42 | MP0001764_abnormal_homeostasis | 1.49475614 |
| 43 | * MP0002557_abnormal_social/conspecific_i | 1.46226298 |
| 44 | MP0002254_reproductive_system_inflammat | 1.43847630 |
| 45 | MP0009697_abnormal_copulation | 1.38534883 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.38266522 |
| 47 | MP0005535_abnormal_body_temperature | 1.37970993 |
| 48 | MP0000920_abnormal_myelination | 1.34599694 |
| 49 | * MP0004742_abnormal_vestibular_system | 1.34234539 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.33429435 |
| 51 | * MP0002066_abnormal_motor_capabilities/c | 1.32811992 |
| 52 | MP0003880_abnormal_central_pattern | 1.32781866 |
| 53 | MP0003632_abnormal_nervous_system | 1.31798075 |
| 54 | * MP0002882_abnormal_neuron_morphology | 1.28242793 |
| 55 | MP0000955_abnormal_spinal_cord | 1.23159176 |
| 56 | MP0003136_yellow_coat_color | 1.20650800 |
| 57 | MP0001501_abnormal_sleep_pattern | 1.19612392 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.19113754 |
| 59 | MP0003690_abnormal_glial_cell | 1.16027769 |
| 60 | MP0003634_abnormal_glial_cell | 1.15696559 |
| 61 | * MP0001963_abnormal_hearing_physiology | 1.15375921 |
| 62 | MP0000751_myopathy | 1.14704776 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.11226859 |
| 64 | MP0004142_abnormal_muscle_tone | 1.10603639 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.10585975 |
| 66 | MP0005647_abnormal_sex_gland | 1.08358380 |
| 67 | MP0000604_amyloidosis | 1.07676640 |
| 68 | * MP0002229_neurodegeneration | 1.05658328 |
| 69 | MP0002249_abnormal_larynx_morphology | 1.05201606 |
| 70 | MP0009643_abnormal_urine_homeostasis | 1.03818221 |
| 71 | MP0003646_muscle_fatigue | 1.03047220 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 1.01703070 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 1.01321968 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 1.00627832 |
| 75 | MP0009764_decreased_sensitivity_to | 1.00480128 |
| 76 | MP0004510_myositis | 1.00377227 |
| 77 | MP0003329_amyloid_beta_deposits | 0.97652199 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 0.97372296 |
| 79 | MP0000749_muscle_degeneration | 0.97116911 |
| 80 | MP0005451_abnormal_body_composition | 0.96982562 |
| 81 | MP0002184_abnormal_innervation | 0.96493641 |
| 82 | MP0006036_abnormal_mitochondrial_physio | 0.96481864 |
| 83 | MP0002152_abnormal_brain_morphology | 0.96024440 |
| 84 | MP0003724_increased_susceptibility_to | 0.94945837 |
| 85 | * MP0000026_abnormal_inner_ear | 0.90858391 |
| 86 | MP0001529_abnormal_vocalization | 0.90482377 |
| 87 | MP0004145_abnormal_muscle_electrophysio | 0.89863133 |
| 88 | MP0005670_abnormal_white_adipose | 0.89685182 |
| 89 | MP0002064_seizures | 0.89409414 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.89151854 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.86984034 |
| 92 | MP0003698_abnormal_male_reproductive | 0.86471488 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.86288005 |
| 94 | MP0002638_abnormal_pupillary_reflex | 0.84410306 |
| 95 | MP0008469_abnormal_protein_level | 0.84286427 |
| 96 | MP0005376_homeostasis/metabolism_phenot | 0.83277078 |
| 97 | MP0001440_abnormal_grooming_behavior | 0.82898525 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.82785068 |
| 99 | MP0009642_abnormal_blood_homeostasis | 0.81869946 |
| 100 | MP0000579_abnormal_nail_morphology | 0.81538956 |
| 101 | MP0008872_abnormal_physiological_respon | 0.81468848 |
| 102 | MP0009745_abnormal_behavioral_response | 0.80402369 |
| 103 | MP0002971_abnormal_brown_adipose | 0.80298977 |
| 104 | MP0004215_abnormal_myocardial_fiber | 0.80243291 |
| 105 | MP0009046_muscle_twitch | 0.77575752 |
| 106 | MP0005334_abnormal_fat_pad | 0.76726302 |
| 107 | MP0003186_abnormal_redox_activity | 0.76651633 |
| 108 | MP0009763_increased_sensitivity_to | 0.76533358 |
| 109 | MP0005646_abnormal_pituitary_gland | 0.76295036 |
| 110 | MP0004381_abnormal_hair_follicle | 0.76234147 |
| 111 | MP0000598_abnormal_liver_morphology | 0.74989086 |
| 112 | MP0008874_decreased_physiological_sensi | 0.74443928 |
| 113 | * MP0002752_abnormal_somatic_nervous | 0.74434625 |
| 114 | MP0009379_abnormal_foot_pigmentation | 0.74086633 |
| 115 | MP0003959_abnormal_lean_body | 0.73225264 |
| 116 | MP0001905_abnormal_dopamine_level | 0.73006571 |
| 117 | MP0005448_abnormal_energy_balance | 0.72863952 |
| 118 | MP0003011_delayed_dark_adaptation | 0.72436449 |
| 119 | MP0005423_abnormal_somatic_nervous | 0.70098688 |
| 120 | MP0003122_maternal_imprinting | 0.69523101 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.69306231 |
| 122 | MP0005408_hypopigmentation | 0.68833485 |
| 123 | MP0000747_muscle_weakness | 0.68455643 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.67295627 |
| 125 | MP0005266_abnormal_metabolism | 0.67009882 |
| 126 | MP0001765_abnormal_ion_homeostasis | 0.65735632 |
| 127 | MP0001968_abnormal_touch/_nociception | 0.65481053 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.65301612 |
| 129 | MP0001346_abnormal_lacrimal_gland | 0.65073539 |
| 130 | MP0003635_abnormal_synaptic_transmissio | 0.63906445 |
| 131 | MP0003953_abnormal_hormone_level | 0.62614403 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.62223484 |
| 133 | MP0005166_decreased_susceptibility_to | 0.61883357 |
| 134 | MP0001984_abnormal_olfaction | 0.61451907 |
| 135 | MP0004130_abnormal_muscle_cell | 0.61182944 |
| 136 | MP0005220_abnormal_exocrine_pancreas | 0.60282650 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.59616736 |
| 138 | MP0002572_abnormal_emotion/affect_behav | 0.58541540 |
| 139 | MP0003879_abnormal_hair_cell | 0.57461942 |
| 140 | MP0002272_abnormal_nervous_system | 0.57364598 |
| 141 | MP0005551_abnormal_eye_electrophysiolog | 0.57169191 |
| 142 | MP0001502_abnormal_circadian_rhythm | 0.55474256 |
| 143 | MP0002090_abnormal_vision | 0.55190837 |
| 144 | MP0002733_abnormal_thermal_nociception | 0.55016496 |
| 145 | * MP0004924_abnormal_behavior | 0.54378812 |
| 146 | * MP0005386_behavior/neurological_phenoty | 0.54378812 |
| 147 | MP0000230_abnormal_systemic_arterial | 0.53478542 |
| 148 | MP0002736_abnormal_nociception_after | 0.52760035 |
| 149 | MP0002069_abnormal_eating/drinking_beha | 0.48712404 |
| 150 | MP0002909_abnormal_adrenal_gland | 0.48319589 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.48254378 |
| 152 | MP0003075_altered_response_to | 0.48198710 |
| 153 | MP0001943_abnormal_respiration | 0.46817113 |
| 154 | * MP0002067_abnormal_sensory_capabilities | 0.46313442 |
| 155 | MP0006082_CNS_inflammation | 0.46081014 |
| 156 | MP0002161_abnormal_fertility/fecundity | 0.45468383 |
| 157 | MP0010769_abnormal_survival | 0.45357815 |
| 158 | MP0003633_abnormal_nervous_system | 0.45170436 |
| 159 | MP0003861_abnormal_nervous_system | 0.44925220 |
| 160 | MP0000343_altered_response_to | 0.44559909 |
| 161 | MP0005620_abnormal_muscle_contractility | 0.44065790 |
| 162 | * MP0003956_abnormal_body_size | 0.43660167 |
| 163 | MP0004036_abnormal_muscle_relaxation | 0.43107188 |
| 164 | MP0004085_abnormal_heartbeat | 0.42415401 |
| 165 | MP0001177_atelectasis | 0.42366316 |
| 166 | MP0010768_mortality/aging | 0.41201066 |
| 167 | MP0000681_abnormal_thyroid_gland | 0.40446922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.35320118 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.42847088 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.41307893 |
| 4 | Abnormality of binocular vision (HP:0011514) | 6.13870738 |
| 5 | Diplopia (HP:0000651) | 6.13870738 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.96432364 |
| 7 | Myokymia (HP:0002411) | 5.89131826 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.66201668 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.63917441 |
| 10 | Xanthomatosis (HP:0000991) | 5.53491580 |
| 11 | Focal motor seizures (HP:0011153) | 5.42880507 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 5.30030574 |
| 13 | Neurofibrillary tangles (HP:0002185) | 4.69184539 |
| 14 | Complement deficiency (HP:0004431) | 4.46282699 |
| 15 | Joint hemorrhage (HP:0005261) | 4.30792585 |
| 16 | Febrile seizures (HP:0002373) | 4.23348647 |
| 17 | Supranuclear gaze palsy (HP:0000605) | 4.22443769 |
| 18 | Action tremor (HP:0002345) | 4.15442540 |
| 19 | Atonic seizures (HP:0010819) | 4.05383004 |
| 20 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.03956803 |
| 21 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.03956803 |
| 22 | Papilledema (HP:0001085) | 3.97408103 |
| 23 | Hyperammonemia (HP:0001987) | 3.95351163 |
| 24 | Ventricular fibrillation (HP:0001663) | 3.94793471 |
| 25 | Hyperglycinemia (HP:0002154) | 3.94562642 |
| 26 | Ketosis (HP:0001946) | 3.93538542 |
| 27 | Hypolipoproteinemia (HP:0010981) | 3.91941180 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.83982034 |
| 29 | Focal seizures (HP:0007359) | 3.79506804 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77743058 |
| 31 | Fat malabsorption (HP:0002630) | 3.71012006 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.64675003 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.64095147 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.58888974 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 3.57501846 |
| 36 | Epidermoid cyst (HP:0200040) | 3.53732430 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.51610406 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.45915827 |
| 39 | Hyperglycinuria (HP:0003108) | 3.42004026 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 3.40660092 |
| 41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.38052070 |
| 42 | Abnormality of glycine metabolism (HP:0010895) | 3.38052070 |
| 43 | Ankle clonus (HP:0011448) | 3.37988344 |
| 44 | Spastic gait (HP:0002064) | 3.33112461 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 3.28145888 |
| 46 | Hemiparesis (HP:0001269) | 3.25447210 |
| 47 | Urinary urgency (HP:0000012) | 3.23314502 |
| 48 | Visual hallucinations (HP:0002367) | 3.21766964 |
| 49 | Hypoalphalipoproteinemia (HP:0003233) | 3.19088127 |
| 50 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.16898914 |
| 51 | Epileptic encephalopathy (HP:0200134) | 3.15452537 |
| 52 | Abnormal eating behavior (HP:0100738) | 3.15124744 |
| 53 | Postural instability (HP:0002172) | 3.15019194 |
| 54 | Morphological abnormality of the pyramidal tract (HP:0002062) | 3.13997725 |
| 55 | Hypoglycemic coma (HP:0001325) | 3.13932468 |
| 56 | Spastic tetraparesis (HP:0001285) | 3.12371239 |
| 57 | Insidious onset (HP:0003587) | 3.11152139 |
| 58 | Termporal pattern (HP:0011008) | 3.11152139 |
| 59 | Dysmetria (HP:0001310) | 3.09728888 |
| 60 | Annular pancreas (HP:0001734) | 3.07460821 |
| 61 | Abnormality of complement system (HP:0005339) | 3.06315893 |
| 62 | Generalized tonic-clonic seizures (HP:0002069) | 3.01205840 |
| 63 | Intention tremor (HP:0002080) | 3.00942358 |
| 64 | Neuronal loss in central nervous system (HP:0002529) | 3.00742837 |
| 65 | Progressive cerebellar ataxia (HP:0002073) | 2.99095927 |
| 66 | Confusion (HP:0001289) | 2.98239333 |
| 67 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.96534019 |
| 68 | Hyperbilirubinemia (HP:0002904) | 2.96222242 |
| 69 | Cerebral edema (HP:0002181) | 2.92207856 |
| 70 | Ketoacidosis (HP:0001993) | 2.92122761 |
| 71 | Mutism (HP:0002300) | 2.91052179 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.89595322 |
| 73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.84492908 |
| 74 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.83698744 |
| 75 | Hypercholesterolemia (HP:0003124) | 2.81298377 |
| 76 | Bronchomalacia (HP:0002780) | 2.81290259 |
| 77 | Delusions (HP:0000746) | 2.77646644 |
| 78 | Steatorrhea (HP:0002570) | 2.77485138 |
| 79 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.77445723 |
| 80 | Spontaneous abortion (HP:0005268) | 2.75382905 |
| 81 | Abnormal pupillary function (HP:0007686) | 2.73738685 |
| 82 | Hemiplegia (HP:0002301) | 2.73121840 |
| 83 | Lethargy (HP:0001254) | 2.71210568 |
| 84 | Absence seizures (HP:0002121) | 2.67759990 |
| 85 | Gout (HP:0001997) | 2.62832205 |
| 86 | Metabolic acidosis (HP:0001942) | 2.59753890 |
| 87 | Neonatal onset (HP:0003623) | 2.56796272 |
| 88 | Peripheral hypomyelination (HP:0007182) | 2.56760381 |
| 89 | Abnormality of serum amino acid levels (HP:0003112) | 2.56697614 |
| 90 | Exercise-induced muscle cramps (HP:0003710) | 2.53082486 |
| 91 | Ulnar claw (HP:0001178) | 2.52172938 |
| 92 | Abnormality of nucleobase metabolism (HP:0010932) | 2.51919892 |
| 93 | Stereotypic behavior (HP:0000733) | 2.49015263 |
| 94 | Dialeptic seizures (HP:0011146) | 2.48518977 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.47797246 |
| 96 | Cholecystitis (HP:0001082) | 2.47797246 |
| 97 | Cerebral hypomyelination (HP:0006808) | 2.46985309 |
| 98 | Hypoglycemic seizures (HP:0002173) | 2.45394682 |
| 99 | Hypochromic microcytic anemia (HP:0004840) | 2.41866392 |
| 100 | Global brain atrophy (HP:0002283) | 2.40765626 |
| 101 | Dicarboxylic aciduria (HP:0003215) | 2.40442135 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40442135 |
| 103 | Brushfield spots (HP:0001088) | 2.40221235 |
| 104 | Dysdiadochokinesis (HP:0002075) | 2.38635607 |
| 105 | Apathy (HP:0000741) | 2.37833643 |
| 106 | Skin nodule (HP:0200036) | 2.36453762 |
| 107 | Bradykinesia (HP:0002067) | 2.36216180 |
| 108 | Abnormality of purine metabolism (HP:0004352) | 2.36030466 |
| 109 | Tetraplegia (HP:0002445) | 2.34715720 |
| 110 | Rigidity (HP:0002063) | 2.34574223 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 2.33832086 |
| 112 | Depression (HP:0000716) | 2.33126955 |
| 113 | Poor eye contact (HP:0000817) | 2.33058052 |
| 114 | Muscle fiber inclusion bodies (HP:0100299) | 2.32972357 |
| 115 | Muscle fiber splitting (HP:0003555) | 2.32253437 |
| 116 | Irritability (HP:0000737) | 2.32091810 |
| 117 | Acanthocytosis (HP:0001927) | 2.32048753 |
| 118 | Obstructive sleep apnea (HP:0002870) | 2.29346640 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 2.28582987 |
| 120 | Amyloidosis (HP:0011034) | 2.26536171 |
| 121 | Menorrhagia (HP:0000132) | 2.25162704 |
| 122 | Cholelithiasis (HP:0001081) | 2.24402793 |
| 123 | Vascular calcification (HP:0004934) | 2.24029886 |
| 124 | Diminished motivation (HP:0000745) | 2.23637780 |
| 125 | Nemaline bodies (HP:0003798) | 2.23130863 |
| 126 | Late onset (HP:0003584) | 2.22240166 |
| 127 | Hepatocellular carcinoma (HP:0001402) | 2.21766852 |
| 128 | Spastic paraparesis (HP:0002313) | 2.21624896 |
| 129 | Sleep apnea (HP:0010535) | 2.20512645 |
| 130 | Lower limb muscle weakness (HP:0007340) | 2.19363840 |
| 131 | Rapidly progressive (HP:0003678) | 2.18927718 |
| 132 | Polyphagia (HP:0002591) | 2.18468391 |
| 133 | Status epilepticus (HP:0002133) | 2.15636147 |
| 134 | Truncal ataxia (HP:0002078) | 2.15443195 |
| 135 | Scanning speech (HP:0002168) | 2.15114880 |
| 136 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.14851881 |
| 137 | Acute encephalopathy (HP:0006846) | 2.13685442 |
| 138 | Exercise-induced myalgia (HP:0003738) | 2.12760994 |
| 139 | Bundle branch block (HP:0011710) | 2.08930789 |
| 140 | Vomiting (HP:0002013) | 2.06815120 |
| 141 | Enlarged kidneys (HP:0000105) | 2.06241059 |
| 142 | Insomnia (HP:0100785) | 2.06183538 |
| 143 | Malnutrition (HP:0004395) | 2.05464857 |
| 144 | Clonus (HP:0002169) | 2.05270122 |
| 145 | Increased circulating renin level (HP:0000848) | 2.04689593 |
| 146 | Myocardial infarction (HP:0001658) | 2.04454857 |
| 147 | Glomerulonephritis (HP:0000099) | 2.04142606 |
| 148 | Abnormal EKG (HP:0003115) | 2.02332148 |
| 149 | Cerebral hemorrhage (HP:0001342) | 2.01924992 |
| 150 | Bowel incontinence (HP:0002607) | 2.01191940 |
| 151 | Myotonia (HP:0002486) | 2.00953150 |
| 152 | Abnormal ciliary motility (HP:0012262) | 1.98982250 |
| 153 | Abnormal social behavior (HP:0012433) | 1.97856261 |
| 154 | Impaired social interactions (HP:0000735) | 1.97856261 |
| 155 | Slow saccadic eye movements (HP:0000514) | 1.96576488 |
| 156 | Glycosuria (HP:0003076) | 1.96572179 |
| 157 | Abnormality of urine glucose concentration (HP:0011016) | 1.96572179 |
| 158 | Foot dorsiflexor weakness (HP:0009027) | 1.95884621 |
| 159 | Prolonged QT interval (HP:0001657) | 1.95816043 |
| 160 | Amblyopia (HP:0000646) | 1.95749652 |
| 161 | Alkalosis (HP:0001948) | 1.95672911 |
| 162 | Axonal loss (HP:0003447) | 1.95165948 |
| 163 | Hepatic necrosis (HP:0002605) | 1.95002039 |
| 164 | Epileptiform EEG discharges (HP:0011182) | 1.94698581 |
| 165 | Nuclear cataract (HP:0100018) | 1.94322389 |
| 166 | Hypothermia (HP:0002045) | 1.92761516 |
| 167 | Syncope (HP:0001279) | 1.92252427 |
| 168 | Fair hair (HP:0002286) | 1.92190438 |
| 169 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91552742 |
| 170 | Cardiovascular calcification (HP:0011915) | 1.91240449 |
| 171 | Mitral stenosis (HP:0001718) | 1.91200692 |
| 172 | Increased muscle lipid content (HP:0009058) | 1.91194463 |
| 173 | Gingival bleeding (HP:0000225) | 1.90603799 |
| 174 | Incomplete penetrance (HP:0003829) | 1.90341139 |
| 175 | Abnormal large intestine physiology (HP:0012700) | 1.90121432 |
| 176 | Turricephaly (HP:0000262) | 1.89917907 |
| 177 | Limb dystonia (HP:0002451) | 1.88754331 |
| 178 | Hyporeflexia of lower limbs (HP:0002600) | 1.87579812 |
| 179 | Acute hepatic failure (HP:0006554) | 1.85567367 |
| 180 | Hyperphosphaturia (HP:0003109) | 1.84129152 |
| 181 | Spastic diplegia (HP:0001264) | 1.83888441 |
| 182 | Systemic lupus erythematosus (HP:0002725) | 1.83695570 |
| 183 | Rickets (HP:0002748) | 1.83595920 |
| 184 | Abnormality of the gallbladder (HP:0005264) | 1.83070525 |
| 185 | Increased intramyocellular lipid droplets (HP:0012240) | 1.82664921 |
| 186 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82027445 |
| 187 | Double outlet right ventricle (HP:0001719) | 1.80749211 |
| 188 | Congenital malformation of the right heart (HP:0011723) | 1.80749211 |
| 189 | Abnormality of the foot musculature (HP:0001436) | 1.80403188 |
| 190 | Thrombophlebitis (HP:0004418) | 1.80264599 |
| 191 | Urinary incontinence (HP:0000020) | 1.79680101 |
| 192 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79636415 |
| 193 | Hepatocellular necrosis (HP:0001404) | 1.77596075 |
| 194 | Pancreatitis (HP:0001733) | 1.77150905 |
| 195 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.76836790 |
| 196 | Symptomatic seizures (HP:0011145) | 1.75342958 |
| 197 | Renal Fanconi syndrome (HP:0001994) | 1.74729195 |
| 198 | Abnormality of vitamin metabolism (HP:0100508) | 1.74051002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.23116617 |
| 2 | EPHA4 | 3.90848979 |
| 3 | FGFR4 | 3.45946739 |
| 4 | MAP2K4 | 3.14238494 |
| 5 | PAK6 | 2.95270720 |
| 6 | PRKD3 | 2.63216879 |
| 7 | SIK1 | 2.60341550 |
| 8 | MAP3K12 | 2.59203687 |
| 9 | PHKG2 | 2.29829683 |
| 10 | PHKG1 | 2.29829683 |
| 11 | TNIK | 2.19390456 |
| 12 | INSRR | 2.17389866 |
| 13 | PNCK | 2.12796602 |
| 14 | PRPF4B | 2.12302870 |
| 15 | CAMKK1 | 2.09147829 |
| 16 | TAOK3 | 2.06770499 |
| 17 | TESK1 | 2.01114347 |
| 18 | NTRK2 | 1.93886278 |
| 19 | PIK3CG | 1.90200955 |
| 20 | LATS2 | 1.79270232 |
| 21 | NEK6 | 1.78921302 |
| 22 | MAP3K13 | 1.76390955 |
| 23 | MAP3K4 | 1.73589695 |
| 24 | MAP2K7 | 1.73103863 |
| 25 | MAPK13 | 1.72161534 |
| 26 | NTRK3 | 1.69591064 |
| 27 | CAMKK2 | 1.68187133 |
| 28 | TAOK1 | 1.64745355 |
| 29 | ERBB4 | 1.61759757 |
| 30 | TYK2 | 1.59243331 |
| 31 | CASK | 1.54904622 |
| 32 | ERN1 | 1.53953634 |
| 33 | PLK2 | 1.51551010 |
| 34 | MAPK15 | 1.49561550 |
| 35 | DAPK2 | 1.49265360 |
| 36 | TYRO3 | 1.47445874 |
| 37 | MARK2 | 1.45799262 |
| 38 | GRK7 | 1.40182843 |
| 39 | CAMK4 | 1.39356281 |
| 40 | RIPK1 | 1.30925589 |
| 41 | GRK6 | 1.27810177 |
| 42 | OBSCN | 1.26966666 |
| 43 | STK38 | 1.26202114 |
| 44 | ADRBK2 | 1.24549729 |
| 45 | MAPKAPK5 | 1.23519817 |
| 46 | CDK5 | 1.21599673 |
| 47 | CSNK1G1 | 1.21530157 |
| 48 | CSNK1G3 | 1.18721179 |
| 49 | PKN2 | 1.14315080 |
| 50 | CAMK2G | 1.11946511 |
| 51 | MST1R | 1.11692627 |
| 52 | ARAF | 1.10381518 |
| 53 | TNK2 | 1.10170817 |
| 54 | KSR2 | 1.09962580 |
| 55 | CAMK2A | 1.07751569 |
| 56 | PINK1 | 1.07297586 |
| 57 | WNK3 | 1.05367069 |
| 58 | CSNK1G2 | 1.02419942 |
| 59 | IRAK2 | 1.01587775 |
| 60 | MAP3K7 | 1.01425348 |
| 61 | JAK2 | 0.99932088 |
| 62 | FLT3 | 0.98814741 |
| 63 | PAK3 | 0.96028908 |
| 64 | PLK4 | 0.91599221 |
| 65 | IRAK1 | 0.91325658 |
| 66 | OXSR1 | 0.90899011 |
| 67 | MINK1 | 0.90739682 |
| 68 | CDK14 | 0.90732312 |
| 69 | NME1 | 0.90624856 |
| 70 | NLK | 0.88300106 |
| 71 | CAMK1G | 0.87261148 |
| 72 | CDK11A | 0.87092593 |
| 73 | WNK4 | 0.86953250 |
| 74 | MAP3K1 | 0.85866023 |
| 75 | CDK15 | 0.85506867 |
| 76 | MAPK11 | 0.85485545 |
| 77 | MUSK | 0.84579167 |
| 78 | MAPK12 | 0.83634927 |
| 79 | CDK18 | 0.82698456 |
| 80 | ROCK2 | 0.82482135 |
| 81 | PRKCG | 0.78774873 |
| 82 | GRK5 | 0.78512903 |
| 83 | IKBKE | 0.77979929 |
| 84 | DYRK1A | 0.76840701 |
| 85 | BMPR2 | 0.74351593 |
| 86 | MAPK4 | 0.73601936 |
| 87 | MAP2K6 | 0.72626948 |
| 88 | TAOK2 | 0.72391335 |
| 89 | PTK6 | 0.72199768 |
| 90 | TXK | 0.71645033 |
| 91 | SGK3 | 0.71433531 |
| 92 | CAMK2B | 0.70867752 |
| 93 | SGK1 | 0.70855667 |
| 94 | NTRK1 | 0.70817029 |
| 95 | JAK1 | 0.70809092 |
| 96 | PRKCZ | 0.70420880 |
| 97 | RIPK4 | 0.69640100 |
| 98 | MOS | 0.69086162 |
| 99 | PRKCQ | 0.69018199 |
| 100 | PRKAA2 | 0.68739993 |
| 101 | RET | 0.67993275 |
| 102 | MAPK10 | 0.67179026 |
| 103 | FES | 0.66835525 |
| 104 | SIK2 | 0.66825531 |
| 105 | MAP3K9 | 0.66104954 |
| 106 | BRAF | 0.65829297 |
| 107 | MAP3K11 | 0.64818439 |
| 108 | PRKCH | 0.63904483 |
| 109 | PDK1 | 0.62774232 |
| 110 | ADRBK1 | 0.61176302 |
| 111 | ABL2 | 0.60969246 |
| 112 | STK39 | 0.59586994 |
| 113 | PRKACG | 0.59174310 |
| 114 | BMPR1B | 0.59048224 |
| 115 | PDPK1 | 0.59029186 |
| 116 | PKN1 | 0.56926423 |
| 117 | DDR2 | 0.56743797 |
| 118 | STK11 | 0.56656518 |
| 119 | SGK223 | 0.56387643 |
| 120 | SGK494 | 0.56387643 |
| 121 | TBK1 | 0.56310426 |
| 122 | CAMK1 | 0.55895547 |
| 123 | LIMK1 | 0.53233989 |
| 124 | DAPK1 | 0.53178377 |
| 125 | KDR | 0.52565023 |
| 126 | MARK1 | 0.51594716 |
| 127 | UHMK1 | 0.51565300 |
| 128 | CAMK2D | 0.50208195 |
| 129 | EPHB1 | 0.50166952 |
| 130 | ZAP70 | 0.50098260 |
| 131 | SGK2 | 0.49920664 |
| 132 | PRKG1 | 0.48409846 |
| 133 | CDK19 | 0.48008401 |
| 134 | TEC | 0.47779267 |
| 135 | TIE1 | 0.47389434 |
| 136 | DYRK3 | 0.47298168 |
| 137 | PRKACA | 0.47122077 |
| 138 | IGF1R | 0.45547240 |
| 139 | ALK | 0.44674984 |
| 140 | DYRK1B | 0.44580096 |
| 141 | GSK3A | 0.44345937 |
| 142 | ITK | 0.43772872 |
| 143 | PRKCA | 0.43668324 |
| 144 | RPS6KA3 | 0.43647349 |
| 145 | MAPK7 | 0.42584087 |
| 146 | FGFR2 | 0.42520176 |
| 147 | BMX | 0.41761977 |
| 148 | DAPK3 | 0.41669357 |
| 149 | MAP3K14 | 0.41342607 |
| 150 | ROCK1 | 0.39341913 |
| 151 | PTK2B | 0.38246992 |
| 152 | ICK | 0.36520597 |
| 153 | LMTK2 | 0.32639694 |
| 154 | FYN | 0.32408331 |
| 155 | MAPK8 | 0.31255523 |
| 156 | WNK1 | 0.30027079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37983991 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.29762387 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.10980877 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.09959152 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.00253400 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.88705884 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79970675 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.66577757 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66093287 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.51858235 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.50369093 |
| 12 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.44470633 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42895158 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.42000178 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31398840 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.29457787 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.27966662 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.27627313 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25989160 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23085840 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.20165463 |
| 22 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09103539 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 2.04759731 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04083261 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.92348950 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.90169441 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89585247 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.87299651 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.86214758 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.82347520 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.81729898 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79866823 |
| 33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.77615063 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75851463 |
| 35 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.74971038 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.74686317 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.73416045 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71611958 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71386875 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70948905 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68871680 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.66210395 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.64527048 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.57528262 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.57066443 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.53528332 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53167908 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50154626 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.49810464 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47050324 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.44662071 |
| 52 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43218753 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 1.41712106 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.41487385 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37628812 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37359684 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.34743081 |
| 58 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28733203 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.23181210 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23082085 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 1.19291542 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.16893430 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16830033 |
| 64 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.16213164 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 1.13612632 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13013492 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12334054 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10957929 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07778788 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 1.06326431 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02816189 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00118653 |
| 73 | Glioma_Homo sapiens_hsa05214 | 0.98581529 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.97240437 |
| 75 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94053825 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93673713 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.93616572 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93151328 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92326707 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92234954 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92017745 |
| 82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91396622 |
| 83 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89685091 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.87760295 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86545027 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84988135 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79799011 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79502998 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77636552 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75621872 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75270939 |
| 92 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75001638 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.72831657 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.71911720 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70347206 |
| 96 | Axon guidance_Homo sapiens_hsa04360 | 0.70333512 |
| 97 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70177361 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68126272 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.68033649 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66666169 |
| 101 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66412911 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65985057 |
| 103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64318303 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64192088 |
| 105 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64147457 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60688939 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60482909 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58533848 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58003921 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57994941 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56550093 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55209302 |
| 113 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53899716 |
| 114 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53618218 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51242569 |
| 116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50880890 |
| 117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50620322 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50421941 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.50178651 |
| 120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48881634 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46757073 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44684821 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44128779 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.42153993 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41361233 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.41146997 |
| 127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.40738709 |
| 128 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36566228 |
| 129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36186129 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34614368 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33352100 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.33063267 |
| 133 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31717886 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30806921 |
| 135 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29562433 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29324577 |
| 137 | Cocaine addiction_Homo sapiens_hsa05030 | 0.28845064 |
| 138 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.28388625 |
| 139 | Alcoholism_Homo sapiens_hsa05034 | 0.28261176 |
| 140 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26890403 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26400983 |
| 142 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24136153 |
| 143 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23162785 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23140868 |
| 145 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16442947 |
| 146 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15649841 |
| 147 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15257571 |
| 148 | Huntingtons disease_Homo sapiens_hsa05016 | 0.14905116 |
| 149 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14440568 |
| 150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.14280159 |
| 151 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14114789 |
| 152 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.10792225 |
| 153 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.10503899 |
| 154 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.10446772 |
| 155 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.10227911 |
| 156 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.08830064 |
| 157 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.06834773 |
| 158 | Taste transduction_Homo sapiens_hsa04742 | 0.05122833 |
| 159 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.03812121 |
| 160 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.02640393 |
| 161 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.01734948 |
| 162 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.01715340 |
| 163 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.01426438 |
| 164 | Renin secretion_Homo sapiens_hsa04924 | 0.01352157 |
| 165 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.00637810 |
| 166 | Morphine addiction_Homo sapiens_hsa05032 | 0.00016360 |
| 167 | Insulin resistance_Homo sapiens_hsa04931 | -0.0117594 |
| 168 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0116053 |

